Company News

Skinvisible Signs Deal with Embil

Anti-acne products now available in Turkey and surrounding countries.

Author Image

By: TOM BRANNA

Editor

Skinvisible, Inc., Las Vegas, has signed an exclusive licensing agreement with Embil Pharmaceutical Co. Ltd. The agreement is for the right to develop and market two of Skinvisible’s prescription anti-acne products formulated with Invisicare and the active ingredients Clindamycin HCL, and retinoic acid. Invisicare is Skinvisible’s patented polymer delivery technology that is said to provide many benefits to topically delivered products including binding to the skin for four hours or ...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters